Biopharmaceutical Industry in North America Countries: Market Research Reports, Statistics and Analysis

Pfizer Inc. - Company Report For Year 2012

... To as Follow-on biologics ). Such biosimilars would reference biotechnology products approved under the u.S. Public health service act. Additionally, the fda has approved a biosimilar recombinant human growth ...

Investor Presentation: Biopharmaceutical In Canada For Year 2012

... Clinical researc tria esign assistance Waiver of prescription drug user fees. Type 1 plasminogen deficiency Plasminogen: plasminogen is a naturally occurring protein synthesized by the liver ...

Company Report: Vaccine In Canada For Year 2013

Company Report: Biopharmaceutical In The United States For Year 2 ...

Intercell Ag - Company Report For Year 2013

... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...

New Enterprise Associates - Company Report For Year 2013

Company Report: Protein In The United States For Year 2013

... Therapeutics for folding diseases or folding solutions are difficult to develop because proteins are moving targets }disease or misfolding n o ye s -high throughput readout signal -- yes/no decrease ...

Vaccine Market Statistics In The United States And Canada

U.s. Antibody Industry Brief

... Selection antibody generation assay development cell line development bio-analytical assay development manufacturing research process optimization product positioning research poc studies additional ...